Latest News
Agili-C™ IDE Clinical Study
Our pivotal study will include US and OUS centers, with the aim of evaluating the safety and effectiveness of Agili-C™ compared to current surgical standard of care in traumatic and arthritic lesions. The study is designed as prospective, multicenter, open-label, randomized and controlled. It will be conducted in accordance with FDA regulations, Declaration of Helsinki, and Good Clinical Practice (GCP) guidelines, and in compliance with the applicable local regulations.

Video Testimonials

Am I eligible?
Find out if you may be a potential participant in the Agili-C™ IDE Clinical study
Refer a patient
Find out if Agili-C™ might be a potential treatment for your patients


Am I eligible?
Find out if you may be a potential participant in the Agili-C™ IDE Clinical study

Refer a patient
Find out if Agili-C™ might be a potential treatment for your patients